Innoviva (INVA) Change in Account Payables (2010 - 2026)
Innoviva posted quarterly Change in Account Payables of $1.6 million for Q1 2026, down 39.56% year-on-year from $2.6 million in Q1 2025, and down 62.25% on a QoQ basis from $4.1 million in Q3 2025.
Innoviva (INVA) has 17 years of Change in Account Payables data on file, last reported at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 39.56% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $8.9 million (up 291.39% YoY), and the FY2025 full-year result was $2.8 million, up 161.81% from the prior year.
- Change in Account Payables for Q1 2026 stood at $1.6 million, down from $4.1 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $4.1 million in Q3 2025 and bottomed at -$5.8 million in Q1 2024.
- The 5-year median for Change in Account Payables is $958000.0 (2022), against an average of $604307.7.
- The widest annual swing landed in 2022, when Change in Account Payables jumped 15618.75%; it then plunged 401.78% in 2024.
- A 5-year view of Change in Account Payables shows it stood at $958000.0 in 2022, then fell by 11.9% to $844000.0 in 2023, then slumped by 401.78% to -$2.5 million in 2024, then jumped by 261.41% to $4.1 million in 2025, then plunged by 62.25% to $1.6 million in 2026.
- The last three Change in Account Payables figures came in at $1.6 million (Q1 2026), $4.1 million (Q3 2025), and $682000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 1.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.55 Mn |
| Mar 31, 2026 | 1.55 Mn |
| Sep 30, 2025 | 4.11 Mn |
| Sep 30, 2025 | 4.11 Mn |
| Jun 30, 2025 | 682,000.00 |
| Jun 30, 2025 | 682,000.00 |
| Mar 31, 2025 | 2.57 Mn |
| Mar 31, 2025 | 2.57 Mn |
| Sep 30, 2024 | -2.55 Mn |
| Sep 30, 2024 | -2.55 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | -5.83 Mn |
| Mar 31, 2024 | -5.83 Mn |
| Sep 30, 2023 | 844,000.00 |
| Sep 30, 2023 | 844,000.00 |
| Jun 30, 2023 | -1.34 Mn |
| Jun 30, 2023 | -1.34 Mn |
| Mar 31, 2023 | 2.99 Mn |
| Mar 31, 2023 | 2.99 Mn |
| Sep 30, 2022 | 958,000.00 |
| Sep 30, 2022 | 958,000.00 |
| Jun 30, 2022 | 2.52 Mn |
| Jun 30, 2022 | 2.52 Mn |
| Mar 31, 2022 | 198,000.00 |
| Mar 31, 2022 | 198,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Jun 30, 2021 | 16,000.00 |
| Jun 30, 2021 | 16,000.00 |
| Mar 31, 2021 | -52,000.00 |
| Mar 31, 2021 | -52,000.00 |
| Dec 31, 2020 | -557,000.00 |
| Dec 31, 2020 | -557,000.00 |
| Sep 30, 2020 | 428,000.00 |
| Sep 30, 2020 | 428,000.00 |
| Jun 30, 2020 | 73,000.00 |
| Jun 30, 2020 | 73,000.00 |
| Mar 31, 2020 | 112,000.00 |
| Mar 31, 2020 | 112,000.00 |
| Dec 31, 2019 | -25,000.00 |
| Dec 31, 2019 | -25,000.00 |
| Sep 30, 2019 | -1.10 Mn |
| Sep 30, 2019 | -1.10 Mn |
| Jun 30, 2019 | 995,000.00 |
| Jun 30, 2019 | 995,000.00 |
| Mar 31, 2019 | 133,000.00 |
| Mar 31, 2019 | 133,000.00 |
| Dec 31, 2018 | -98,000.00 |
| Dec 31, 2018 | -98,000.00 |
| Sep 30, 2018 | 51,000.00 |
| Sep 30, 2018 | 51,000.00 |
| Jun 30, 2018 | -8,000.00 |
| Jun 30, 2018 | -8,000.00 |
| Mar 31, 2018 | -535,000.00 |
| Mar 31, 2018 | -535,000.00 |
| Dec 31, 2017 | -28,000.00 |
| Dec 31, 2017 | -28,000.00 |
| Sep 30, 2017 | 352,000.00 |
| Sep 30, 2017 | 352,000.00 |
| Jun 30, 2017 | -2.03 Mn |
| Jun 30, 2017 | -2.03 Mn |
| Mar 31, 2017 | 2.18 Mn |
| Mar 31, 2017 | 2.18 Mn |
| Dec 31, 2016 | -400,000.00 |
| Dec 31, 2016 | -400,000.00 |
| Sep 30, 2016 | 391,000.00 |
| Sep 30, 2016 | 391,000.00 |
| Jun 30, 2016 | -439,000.00 |
| Jun 30, 2016 | -439,000.00 |
| Mar 31, 2016 | -242,000.00 |
| Mar 31, 2016 | -242,000.00 |
| Dec 31, 2015 | 1.87 Mn |
| Dec 31, 2015 | 1.87 Mn |
| Sep 30, 2015 | -150,000.00 |
| Sep 30, 2015 | -150,000.00 |
| Jun 30, 2015 | -1.93 Mn |
| Jun 30, 2015 | -1.93 Mn |
| Mar 31, 2015 | 1.03 Mn |
| Mar 31, 2015 | 1.03 Mn |
| Dec 31, 2014 | 8.47 Mn |
| Dec 31, 2014 | 8.47 Mn |
| Sep 30, 2014 | -14.43 Mn |
| Sep 30, 2014 | -14.43 Mn |
| Jun 30, 2014 | -1.74 Mn |
| Jun 30, 2014 | -1.74 Mn |
| Jun 30, 2013 | 221,000.00 |
| Jun 30, 2013 | 221,000.00 |
| Mar 31, 2013 | -221,000.00 |
| Mar 31, 2013 | -221,000.00 |
| Dec 31, 2012 | 452,000.00 |
| Dec 31, 2012 | 452,000.00 |
| Sep 30, 2012 | -371,000.00 |
| Sep 30, 2012 | -371,000.00 |
| Jun 30, 2012 | -129,000.00 |
| Jun 30, 2012 | -129,000.00 |
| Mar 31, 2012 | 48,000.00 |
| Mar 31, 2012 | 48,000.00 |
| Dec 31, 2011 | 1.86 Mn |
| Dec 31, 2011 | 1.86 Mn |
| Sep 30, 2011 | 633,000.00 |
| Sep 30, 2011 | 633,000.00 |
| Jun 30, 2011 | 615,000.00 |
| Jun 30, 2011 | 615,000.00 |
| Mar 31, 2011 | 198,000.00 |
| Mar 31, 2011 | 198,000.00 |
| Dec 31, 2010 | -330,000.00 |
| Dec 31, 2010 | -330,000.00 |
| Sep 30, 2010 | 377,000.00 |
| Sep 30, 2010 | 377,000.00 |